NDC 23155-035

Moexipril hydrochloride and hydrochlorothiazide

Moexipril Hydrochloride And Hydrochlorothiazide

Moexipril hydrochloride and hydrochlorothiazide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Heritage Pharmaceuticals Inc.. The primary component is Moexipril Hydrochloride; Hydrochlorothiazide.

Product ID23155-035_d4ae2984-5dd8-45d9-8a40-35ef92519e44
NDC23155-035
Product TypeHuman Prescription Drug
Proprietary NameMoexipril hydrochloride and hydrochlorothiazide
Generic NameMoexipril Hydrochloride And Hydrochlorothiazide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-03-20
Marketing CategoryANDA / ANDA
Application NumberANDA202150
Labeler NameHeritage Pharmaceuticals Inc.
Substance NameMOEXIPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Active Ingredient Strength8 mg/1; mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 23155-035-01

100 TABLET, FILM COATED in 1 BOTTLE (23155-035-01)
Marketing Start Date2014-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 23155-035-05 [23155003505]

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202150
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-03-07
Marketing End Date2014-03-08

NDC 23155-035-01 [23155003501]

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202150
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-03-07
Marketing End Date2014-03-08

Drug Details

Active Ingredients

IngredientStrength
MOEXIPRIL HYDROCHLORIDE7.5 mg/1

OpenFDA Data

SPL SET ID:bdbbb1d1-aaf6-4e36-8754-f5757b31303d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1299859
  • 1299890
  • 1299871
    • UPC Code
  • 0323155036015

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "Moexipril hydrochloride and hydrochlorothiazide" or generic name "Moexipril Hydrochloride And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0093-5213Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    0093-5214Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    0093-5215Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    23155-035Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    23155-036Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    23155-037Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    42291-576Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    42291-577Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    42291-578Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-205Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-206Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-207Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.